Annual CFO
-$118.69 M
+$19.63 M+14.19%
31 December 2023
Summary:
ADC Therapeutics SA annual cash flow from operations is currently -$118.69 million, with the most recent change of +$19.63 million (+14.19%) on 31 December 2023. During the last 3 years, it has risen by +$50.04 million (+29.66%). ADCT annual CFO is now -58.36% below its all-time high of -$74.94 million, reached on 31 December 2017.ADCT Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$25.04 M
+$7.80 M+23.75%
30 September 2024
Summary:
ADC Therapeutics SA quarterly cash flow from operations is currently -$25.04 million, with the most recent change of +$7.80 million (+23.75%) on 30 September 2024. Over the past year, it has increased by +$11.63 million (+31.71%). ADCT quarterly CFO is now -1240.91% below its all-time high of $2.19 million, reached on 30 September 2022.ADCT Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$133.62 M
+$11.63 M+8.01%
30 September 2024
Summary:
ADC Therapeutics SA TTM cash flow from operations is currently -$133.62 million, with the most recent change of +$11.63 million (+8.01%) on 30 September 2024. Over the past year, it has increased by +$7.05 million (+5.01%). ADCT TTM CFO is now -316.22% below its all-time high of -$32.10 million, reached on 01 March 2020.ADCT TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ADCT Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +14.2% | +31.7% | +5.0% |
| 3 y3 years | +29.7% | +57.3% | +40.2% |
| 5 y5 years | +2.2% | - | - |
ADCT Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +49.1% | -1240.9% | +59.4% | -31.3% | +42.8% |
| 5 y | 5 years | at high | +49.1% | -1240.9% | +59.4% | -316.2% | +42.8% |
| alltime | all time | -58.4% | +49.1% | -1240.9% | +59.4% | -316.2% | +42.8% |
ADC Therapeutics SA Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$25.04 M(-23.8%) | -$133.62 M(-8.0%) |
| June 2024 | - | -$32.84 M(-25.5%) | -$145.25 M(-1.5%) |
| Mar 2024 | - | -$44.09 M(+39.4%) | -$147.39 M(+24.2%) |
| Dec 2023 | -$118.69 M(-14.2%) | -$31.63 M(-13.7%) | -$118.69 M(-15.6%) |
| Sept 2023 | - | -$36.67 M(+4.8%) | -$140.67 M(+38.2%) |
| June 2023 | - | -$34.99 M(+127.3%) | -$101.80 M(-15.0%) |
| Mar 2023 | - | -$15.39 M(-71.3%) | -$119.82 M(-13.4%) |
| Dec 2022 | -$138.31 M(-40.7%) | -$53.61 M(-2542.6%) | -$138.31 M(-5.5%) |
| Sept 2022 | - | $2.19 M(-104.1%) | -$146.33 M(-29.3%) |
| June 2022 | - | -$53.01 M(+56.5%) | -$207.11 M(-2.4%) |
| Mar 2022 | - | -$33.88 M(-45.0%) | -$212.11 M(-9.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$233.38 M(+38.3%) | -$61.63 M(+5.2%) | -$233.38 M(+4.4%) |
| Sept 2021 | - | -$58.59 M(+1.0%) | -$223.44 M(+6.8%) |
| June 2021 | - | -$58.01 M(+5.2%) | -$209.14 M(+9.1%) |
| Mar 2021 | - | -$55.15 M(+6.7%) | -$191.78 M(+13.7%) |
| Dec 2020 | -$168.73 M(+38.8%) | -$51.69 M(+16.7%) | -$168.73 M(+44.2%) |
| Sept 2020 | - | -$44.29 M(+9.0%) | -$117.03 M(+60.9%) |
| June 2020 | - | -$40.65 M(+26.6%) | -$72.75 M(+126.6%) |
| Mar 2020 | - | -$32.10 M | -$32.10 M |
| Dec 2019 | -$121.58 M(+0.2%) | - | - |
| Dec 2018 | -$121.36 M(+61.9%) | - | - |
| Dec 2017 | -$74.94 M | - | - |
FAQ
- What is ADC Therapeutics SA annual cash flow from operations?
- What is the all time high annual CFO for ADC Therapeutics SA?
- What is ADC Therapeutics SA annual CFO year-on-year change?
- What is ADC Therapeutics SA quarterly cash flow from operations?
- What is the all time high quarterly CFO for ADC Therapeutics SA?
- What is ADC Therapeutics SA quarterly CFO year-on-year change?
- What is ADC Therapeutics SA TTM cash flow from operations?
- What is the all time high TTM CFO for ADC Therapeutics SA?
- What is ADC Therapeutics SA TTM CFO year-on-year change?
What is ADC Therapeutics SA annual cash flow from operations?
The current annual CFO of ADCT is -$118.69 M
What is the all time high annual CFO for ADC Therapeutics SA?
ADC Therapeutics SA all-time high annual cash flow from operations is -$74.94 M
What is ADC Therapeutics SA annual CFO year-on-year change?
Over the past year, ADCT annual cash flow from operations has changed by +$19.63 M (+14.19%)
What is ADC Therapeutics SA quarterly cash flow from operations?
The current quarterly CFO of ADCT is -$25.04 M
What is the all time high quarterly CFO for ADC Therapeutics SA?
ADC Therapeutics SA all-time high quarterly cash flow from operations is $2.19 M
What is ADC Therapeutics SA quarterly CFO year-on-year change?
Over the past year, ADCT quarterly cash flow from operations has changed by +$11.63 M (+31.71%)
What is ADC Therapeutics SA TTM cash flow from operations?
The current TTM CFO of ADCT is -$133.62 M
What is the all time high TTM CFO for ADC Therapeutics SA?
ADC Therapeutics SA all-time high TTM cash flow from operations is -$32.10 M
What is ADC Therapeutics SA TTM CFO year-on-year change?
Over the past year, ADCT TTM cash flow from operations has changed by +$7.05 M (+5.01%)